Trials / Conditions / Recurrent Uterine Corpus Cancer
Recurrent Uterine Corpus Cancer
4 registered clinical trials studyying Recurrent Uterine Corpus Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer NCT02728258 | NRG Oncology | Phase 2 |
| Terminated | Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal NCT02059265 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT01935973 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer NCT00492778 | GOG Foundation | Phase 2 |